{
  "docId": "019dd923-622c-750b-8b9a-3bcd52c6e583",
  "docSlug": "f06b0b5d2079",
  "documentTitle": "Soleno Therapeutics (SLNO)",
  "authorId": "58_Scorpion_Capital",
  "authorName": "Scorpion Capital",
  "documentKindSlug": "activist-deck",
  "documentKindLabel": "Activist deck",
  "sourceTypeSlug": "short_seller",
  "sourceTypeLabel": "Short seller",
  "presentationDate": "2025-08-15 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.3333334,
  "pageNumber": 402,
  "pageCount": 415,
  "prevPage": 401,
  "nextPage": 403,
  "slideType": "quote_slide",
  "function": "expose_contradiction",
  "density": "dense",
  "nDataPoints": 0,
  "notes": "The slide highlights a potential competitive threat to Vykat from generic diazoxide.",
  "elementsJson": [
    "paragraph",
    "quote_block"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622c-750b-8b9a-3bcd52c6e583/402",
  "deckHref": "/decks/019dd923-622c-750b-8b9a-3bcd52c6e583",
  "deckJsonHref": "/decks/019dd923-622c-750b-8b9a-3bcd52c6e583.json",
  "deckAnchorHref": "/decks/019dd923-622c-750b-8b9a-3bcd52c6e583#slide-402",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "I'm probably going to switch everybody over to the generic anyway...I was willing to give the branded option a try on that first one, see what it's like, and get a little experience with it...but long-term, definitely not...why would you do that?",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd953-64ce-7561-b2b7-8a27da97e3dd",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.86,
        "x": 0.07,
        "y": 0.45
      },
      "kind": "paragraph",
      "text": "Strong bias to using generic diazoxide instead of Vykat in it hypothetically has any benefit; \"going to switch everybody over to the generic anyway\"; \"easy\" and \"straightforward\" to \"just go with generic diazoxide\"",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1d03cb80-4eff-4338-b7f7-f7eb37e87127",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.86,
        "x": 0.07,
        "y": 0.53
      },
      "kind": "quote",
      "text": "Q: \"Why would anybody use a tablet versus an oral suspension, even if they're enthusiastic about the data? One is inexpensive. One is half a million or 1 million per year.\"\nA: \"No, it's exactly right...\"",
      "attrs": null,
      "subkind": "testimonial",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b2b233ed-e091-4c36-9d43-fef99363635f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "quote",
      "text": "I've always known that there was a generic diazoxide agent. If I had decided that it seems like it actually does seem to help, at least some subgroup, then I probably was going to use the generic in all of those patients... I'm probably going to switch everybody over to the generic anyway. I was willing to give the branded option a try on that first one, see what it's like, and get a little experience with it. But long-term, definitely not. Why would you do that? ... It's not like it's that hard to figure out...the \"what do you do\" is pretty straightforward...I would just go with generic diazoxide. — Endocrinologist in TX, private practice with 5 PWS patients",
      "attrs": null,
      "subkind": null,
      "toolName": "Authority citation",
      "toolSlug": "authority-citation",
      "confidence": null,
      "componentId": "019dd953-64ce-7561-b2b7-8edd54f4086f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.3,
        "x": 0.07,
        "y": 0.95
      },
      "kind": "source-note",
      "text": "Source: Scorpion Capital consultation calls with experts",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "274a5b3f-3e6d-41f6-8a7a-77d2aa9f7f4c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.86,
        "x": 0.07,
        "y": 0.07
      },
      "kind": "title",
      "text": "The endocrinologist emphasized that he would just use generic diazoxide if Vykat had any value in PWS, and indicated that he substitutes inexpensive generic GLP-1's all the time vs. branded versions",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1ea0ede7-3141-4ac0-b5b4-021e01c469e3",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "ceo-quote-contradiction",
      "slug": null,
      "matchId": "0d39abaa-2ecf-403c-8b85-a354db3d801f",
      "evidence": "The slide uses a direct expert quote to contradict the value proposition of the branded product (Vykat).",
      "confidence": 0.85
    }
  ],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}